Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Florentina Alina Dumitru (London, UK). YS5: The influence of glucocorticoid therapy on trancription factor balance in asthma patients. Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease

Member's Comments

No comment yet.

Related content which might interest you: Steroid therapy as an environmental factor in asthmatic patients: Drifting towards COPD Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2010 Involvement of epigenetic factor in regulation of steroid resistant bronchial asthma patients Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018 The cell haemostasis changes under the glucocorticoid therapy influence in patients with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 230s Year: 2006 Corticosteroid effects on cell signalling Source: Eur Respir J 2006; 27: 413-426 Year: 2006 The influence of multiple intervention factors on the secretion of Th-cells in asthma patients Source: Eur Respir J 2001; 18: Suppl. 33, 431s Year: 2001 Asthma and diabetes: Possible markers of their co-existence. The possible role of transcription factors GATA-3 and T-bet and negative regulator of transcription SOCS1 in the worsening of asthma Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 COPD and asthma: the effect of glucocorticosteroid therapy on tolerance to physical activity Source: Eur Respir J 2005; 26: Suppl. 49, 295s Year: 2005 Glucocorticoid-induced adrenal suppression and metabolic syndrome in glucocorticoid treated AECOPD patients related to different gene polymorphisms of the glucocorticoid receptor gene Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 The role of transcription factor PAX-5 (BSAP) in asthma severity and in the activity of allergic inflammation Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012 Platelet activating factor receptor (PAFr) expression is increased in airways of COPD patients but is not attenuated by inhaled corticosteroid (ICS) Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 T-cell susceptibility to glucocorticoid (GC)-induced apoptosis: the role in asthma pathogenesis and therapy Source: Eur Respir J 2006; 28: Suppl. 50, 227s Year: 2006 COPD management: finding patient related factor of non-adherence Source: Annual Congress 2009 - Oxygen, end-of-life and care for chronic respiratory patients Year: 2009 Protective effect of transcription factor PAX-5 (BSAP) on asthma severity Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Bronchodiator therapy in COPD: physiological effects Source: Breathe 2008; 4: 342-344 Year: 2008 Effect of systemic glucocorticoids on TRPM8 expression in asthma patients Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020 Which are the factors and causes that lead to omalizumab withdrawal in severe asthma patients? Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Muscle regrowth in COPD patients induced by anabolic steroids is amplified by systemic glucocorticoids (GC): A potentiating interaction between GC and IGF-1? Source: Annual Congress 2011 - Challenges in chronic disease management: helping individuals with chronic lung disease remain stable Year: 2011 Corticosteroids: use and insensitivity in severe asthma Source: Eur Respir Mon 2011; 51: 236-252 Year: 2011 Is asthma a risk factor for severe outcomes in COVID 19? Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials Year: 2021 Does azithromycin-prednisolone combination therapy have additive effects than single therapy in patients with persistent asthma? Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009